Compositions and methods for treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer
US11896678B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 28, 2018 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Jan 11, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods for the treatment of PPARG activated cancer. For example, the present disclosure provides PPARG signaling modulators for the treatment of bladder cancer. In particular, therapeutic and/or prophylactic compositions and uses of PPARG inverse-agonists are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.